Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
David E Fisher
Affiliation
Cutaneous Biology Research Center, Mass. General Hospital, Harvard Medical School
ORCID
Career Start Year
1983
Papers
313
H Index
89
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36862513
A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis.
J Clin Invest
2023
37344597
B-cell-specific checkpoint molecules that regulate anti-tumour immunity.
Nature
2023
36834954
The Complex Interplay between Nevi and Melanoma: Risk Factors and Precursors.
Int J Mol Sci
2023
36588115
A unique hyperdynamic dimer interface permits small molecule perturbation of the melanoma oncoprotein MITF for melanoma therapy.
Cell Res
2023
36959380
Functional genomics of human clear cell sarcoma: genomic, transcriptomic and chemical biology landscape for clear cell sarcoma.
Br J Cancer
2023
37019082
NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer.
Cell Metab
2023
37198474
Salvage of ribose from uridine or RNA supports glycolysis in nutrient-limited conditions.
Nat Metab
2023
36634707
Targeting TBK1 to overcome resistance to cancer immunotherapy.
Nature
2023
37256936
Gene-edited and -engineered stem cell platform drives immunotherapy for brain metastatic melanomas.
Sci Transl Med
2023
37063845
mRNA melanoma vaccine revolution spurred by the COVID-19 pandemic.
Front Immunol
2023
36745048
Discovery of Targets for Immune-Metabolic Antitumor Drugs Identifies Estrogen-Related Receptor Alpha.
Cancer Discov
2023
36862513
A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis.
J Clin Invest
2023
37256936
Gene-edited and -engineered stem cell platform drives immunotherapy for brain metastatic melanomas.
Sci Transl Med
2023
37019082
NRF2 activation induces NADH-reductive stress, providing a metabolic vulnerability in lung cancer.
Cell Metab
2023
37344597
B-cell-specific checkpoint molecules that regulate anti-tumour immunity.
Nature
2023
37198474
Salvage of ribose from uridine or RNA supports glycolysis in nutrient-limited conditions.
Nat Metab
2023
37063845
mRNA melanoma vaccine revolution spurred by the COVID-19 pandemic.
Front Immunol
2023
36959380
Functional genomics of human clear cell sarcoma: genomic, transcriptomic and chemical biology landscape for clear cell sarcoma.
Br J Cancer
2023
36588115
A unique hyperdynamic dimer interface permits small molecule perturbation of the melanoma oncoprotein MITF for melanoma therapy.
Cell Res
2023
36745048
Discovery of Targets for Immune-Metabolic Antitumor Drugs Identifies Estrogen-Related Receptor Alpha.
Cancer Discov
2023
36834954
The Complex Interplay between Nevi and Melanoma: Risk Factors and Precursors.
Int J Mol Sci
2023
36634707
Targeting TBK1 to overcome resistance to cancer immunotherapy.
Nature
2023
35131084
Dual Targeting with EZH2 Inhibitor and STING Agonist to Treat Melanoma.
J Invest Dermatol
2022
35561684
Topical therapy for regression and melanoma prevention of congenital giant nevi.
Cell
2022
36525492
β-Endorphin mediates radiation therapy fatigue.
Sci Adv
2022
35131084
Dual Targeting with EZH2 Inhibitor and STING Agonist to Treat Melanoma.
J Invest Dermatol
2022
35561684
Topical therapy for regression and melanoma prevention of congenital giant nevi.
Cell
2022
36525492
β-Endorphin mediates radiation therapy fatigue.
Sci Adv
2022
32268150
Treatment of Advanced Melanoma in 2020 and Beyond.
J Invest Dermatol
2021
35663368
The role of MiT/TFE family members in autophagy regulation.
Curr Top Biochem Res
2021
32268150
Treatment of Advanced Melanoma in 2020 and Beyond.
J Invest Dermatol
2021
33811065
Reduced MC4R signaling alters nociceptive thresholds associated with red hair.
Sci Adv
2021
34233163
NNT mediates redox-dependent pigmentation via a UVB- and MITF-independent mechanism.
Cell
2021
34117054
Vitamin D deficiency exacerbates UV/endorphin and opioid addiction.
Sci Adv
2021
33794192
CYP27A1-dependent anti-melanoma activity of limonoid natural products targets mitochondrial metabolism.
Cell Chem Biol
2021
33504438
The Melanocyte Lineage Factor miR-211 Promotes BRAF<sup>V600E</sup> Inhibitor Resistance.
J Invest Dermatol
2021
33759772
Biology of Melanoma.
Hematol Oncol Clin North Am
2021
33598985
Stress-associated ectopic differentiation of melanocyte stem cells and ORS amelanotic melanocytes in an ex vivo human hair follicle model.
Exp Dermatol
2021
33597266
Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses.
Sci Transl Med
2021
33320376
Skin pigmentation and its control: From ultraviolet radiation to stem cells.
Exp Dermatol
2021
33414132
The State of Melanoma: Emergent Challenges and Opportunities.
Clin Cancer Res
2021
33382172
Melanocortin 1 receptor is dispensable for acute stress induced hair graying in mice.
Exp Dermatol
2021
34565559
MFN2 Stabilization: A Bridge for Endoplasmic Reticulum Stress Sensitivity in Melanoma.
J Invest Dermatol
2021
34728538
SOX10 Regulates Melanoma Immunogenicity through an IRF4-IRF1 Axis.
Cancer Res
2021
34956734
Commentary on NNT Mediates Redox-Dependent Pigmentation <i>via</i> a UVB-And MITF-Independent Mechanism.
J Cell Sci Ther
2021
34691767
G9a: An Emerging Epigenetic Target for Melanoma Therapy.
Epigenomes
2021
35663368
The role of MiT/TFE family members in autophagy regulation.
Curr Top Biochem Res
2021
33794192
CYP27A1-dependent anti-melanoma activity of limonoid natural products targets mitochondrial metabolism.
Cell Chem Biol
2021
33598985
Stress-associated ectopic differentiation of melanocyte stem cells and ORS amelanotic melanocytes in an ex vivo human hair follicle model.
Exp Dermatol
2021
33597266
Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses.
Sci Transl Med
2021
1 - 50 of 626
Column Actions
Search
Recommended Authors
Kerrie L Marie
The University of Manchester
Career Start Year
2015
Number of shared co-authors
14
Andrew McNeal
University of California San Francisco
Career Start Year
2014
Number of shared co-authors
1
Manoela Tiago
Thomas Jefferson University
Career Start Year
2011
Number of shared co-authors
5
Helen T Michael
National Cancer Institute, National Institutes of Health
Career Start Year
2010
Number of shared co-authors
9
Aleksandra M Michalowski
Center for Cancer Research, National Cancer Institute
Career Start Year
2010
Number of shared co-authors
8
Giuseppina Claps
Institut National de la Sante et de la Recherche Medicale (INSERM) U
Career Start Year
2010
Number of shared co-authors
7
Julien Debbache
Institute of Anatomy, University of Zurich
Career Start Year
2009
Number of shared co-authors
16
Mitchell P Levesque
University Hospital Zurich
Career Start Year
2009
Number of shared co-authors
28
Rahul Kumar
Roswell Park Comprehensive Cancer Center
Career Start Year
2009
Number of shared co-authors
1
Steven E Robinson
University of Colorado Anschutz Medical Campus
Career Start Year
2008
Number of shared co-authors
12
Phil F Cheng
University Hospital of Zurich
Career Start Year
2007
Number of shared co-authors
21
Daniel J Coleman
Knight Cancer Institute, Oregon Health & Science University
Career Start Year
2007
Number of shared co-authors
1
Michael P O'Connell
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year
2007
Number of shared co-authors
7
Vijay Walia
National Center for Toxicological Research
Career Start Year
2006
Number of shared co-authors
4
Yongmei Feng
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
2002
Number of shared co-authors
13
Chi-Ping Day
Center for Cancer Research, National Cancer Institute
Career Start Year
2002
Number of shared co-authors
15
Daniela Mihic-Probst
University Hospital Zurich
Career Start Year
2001
Number of shared co-authors
9
Daniel Zingg
Netherlands Cancer Institute
Career Start Year
2001
Number of shared co-authors
7
Ina Poser
Max Planck Institute of Molecular Cell Biology and Genetics
Career Start Year
2001
Number of shared co-authors
0
Todd D Prickett
National Cancer Institute
Career Start Year
2000
Number of shared co-authors
9
Travis J Hollmann
Memorial Sloan Kettering Cancer Center
Career Start Year
1998
Number of shared co-authors
9
Agnes Viale
Memorial Sloan Kettering Cancer Center
Career Start Year
1996
Number of shared co-authors
16
Suzanne Carreira
The Institute of Cancer Research
Career Start Year
1990
Number of shared co-authors
9
Thomas J Hornyak
University of Maryland School of Medicine
Career Start Year
1989
Number of shared co-authors
6
Daniel S Peeper
Netherlands Cancer Institute
Career Start Year
1987
Number of shared co-authors
13
Anthony E Oro
Stanford University
Career Start Year
1985
Number of shared co-authors
0
Molly Kulesz-Martin
Oregon Health & Science University
Career Start Year
1980
Number of shared co-authors
4
Alexander Kamb
Inc. 30301 Agoura Rd.
Career Start Year
1979
Number of shared co-authors
2
Margaret A Tucker
National Cancer Institute
Career Start Year
1976
Number of shared co-authors
18
Menashe Bar-Eli
The University of Texas MD Anderson Cancer Center
Career Start Year
1975
Number of shared co-authors
12
row(s) 1 - 30 of 30
Collaborators
Jennifer A Wargo
Co-authored papers
12
Jun S Song
University of Illinois at Urbana-Champaign
Co-authored papers
11
Levi A Garraway
Broad Institute of Harvard and MIT
Co-authored papers
10
Kathleen C Robinson
Massachusetts General Hospital, Harvard Medical School
Co-authored papers
9
Marcus Bosenberg
Yale School of Medicine
Co-authored papers
6
Adriano Piris
Co-authored papers
6
John M Kirkwood
UPMC Hillman Cancer Center
Co-authored papers
5
William R Sellers
Co-authored papers
5
Matthew Meyerson
Broad Institute
Co-authored papers
4
Mai P Hoang
Co-authored papers
4
Alan C Geller
Harvard TH Chan School of Public Health
Co-authored papers
4
Lynda Chin
Co-authored papers
4
Jeffrey E Gershenwald
The University of Texas MD Anderson Cancer Center
Co-authored papers
4
Michael A Davies
The University of Texas MD Anderson Cancer Center
Co-authored papers
4
Eir??kur Steingr??msson
BioMedical Center, University of Iceland
Co-authored papers
4
Xiaole Shirley Liu
Co-authored papers
4
Glenn Merlino
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers
4
Meenhard Herlyn
Ellen and Ronald Caplan Cancer Center, The Wistar Institute
Co-authored papers
4
Mark A Rubin
University of Bern
Co-authored papers
4
Todd R Golub
Broad Institute of MIT and Harvard
Co-authored papers
4
Clifford A Meyer
Co-authored papers
4
Leslie Lehmann
Dana Farber Cancer Institute/Boston Children's Hospital
Co-authored papers
3
Bing Zhang
Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University
Co-authored papers
3
Ya-Chieh Hsu
Harvard University
Co-authored papers
3
Dave S B Hoon
Saint John's Cancer Institute at Saint John's Health Center
Co-authored papers
3
Yinsheng Wang
Co-authored papers
3
David L Rimm
Yale University School of Medicine
Co-authored papers
3
Christopher L Corless
Oregon Health & Science University
Co-authored papers
3
Ramnik J Xavier
Broad Institute of MIT and Harvard
Co-authored papers
3
Lionel Larue
Institut Curie, PSL Research University, INSERM U1021
Co-authored papers
3
1 - 30